3 items2 sources3 stocks
Seeking Alpha-Nov 4, 06:25 PM
Royalty Pharma raises 2026 portfolio receipts guidance to $3.5B-$3.55B while outlining $1.7B-plus future peak royalties
Royalty Pharma raises 2026 portfolio receipts guidance to $3.5B-$3.55B while outlining $1.7B-plus future peak royalties(摘要待生成)
The Motley Fool-Nov 4, 07:13 PM
Royalty Pharma (RPRX) Q3 2026 Earnings Call Transcript
Royalty Pharma (RPRX) Q3 2026 Earnings Call Transcript(摘要待生成)
The Motley Fool-Nov 8, 03:15 PM
Why Royalty Pharma Investors Could Be the Quiet Winners From Revolution Medicines' Groundbreaking Pancreatic Cancer Drug
Why Royalty Pharma Investors Could Be the Quiet Winners From Revolution Medicines' Groundbreaking Pancreatic Cancer Drug(摘要待生成)